Table 3.
Crosstable between risk factors and type of resistant TB
| Demographic variables | Monoresistant | MDR | Polyresistant | P-value* | |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 123 (79.6%) | 32 (84.2%) | 21 (72.4%) | 0583 | |
| Female | 31 (20.1%) | 6 (15.8%) | 8 (27.6%) | ||
| Nationality | |||||
| Indian Subcontinent | 95 (61.7%) | 31 (81.6%) | 15 (51.7%) | 0.037 | |
| South East Asia | 36 (23.4%) | 4 (10.5%) | 4 (13.8%) | ||
| Middle East | 10 (6.5%) | 1 (2.6%) | 2 (6.8%) | ||
| African | 10 (6.5%) | 1 (2.6%) | 8 (27.6%) | ||
| Others | 3 (1.9%) | 1 (2.6%) | 0 (0%) | ||
| Previous history of tuberculosis | |||||
| Yes | 3 (1.9%) | 1 (2.6%) | 0 (0%) | 0.959 | |
| No | 151 (98.1%) | 37 (97.4%) | 29 (100%) | ||
| Site of disease | |||||
| Pulmonary | 121 (78.5%) | 35 (92.1%) | 24 (82.8%) | 0.239 | |
| Extra pulmonary | 33 (21.4%) | 3 (7.9%) | 5 (17.2%) | ||
| Chest radiograph finding | |||||
| Cavitary | 29 (18.8%) | 9 (23.7%) | 13 (44.8%) | 0.019 | |
| Non cavitary | 125 (81.2%) | 29 (76.3%) | 16 (55.2%) | ||
| Associated comorbidities | |||||
| Yes | 15 (9.7%) | 9 (23.7%) | 13 (44.8%) | 0.555 | |
| No | 139 (81.2%) | 29 (76.3%) | 16 (55.2%) | ||
| Medical commission referral | |||||
| Yes | 94 (61%) | 26 (68.4%) | 3 (10.3%) | 0.361 | |
| No | 60 (39%) | 12 (31.6%) | 26 (89.7%) | ||
| Culture conversion at 2 months | |||||
| Yes | 70 (97.2%) | 14 (100%) | 11 (78.6%) | 0.104 | |
| No | 2 (2.8%) | 0 (0%) | 3 (21.4%) | ||
| Treatment outcome | |||||
| Cured | 60 (96.8%) | 11 (100%) | 12 (100%) | 0.818 | |
| Relapsed | 2 (3.2%) | 0 (0%) | 0 (0%) | ||
*P-values computed using Pearson Chi-Square and Yates corrected Chi-Square statistical tests.
Two patients presented with XDR were excluded from the comparative statistical analysis and computation of statistical P-values